Vimarsana
Biggest News Aggregation in the World

Page 6 - Events Presentations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Events Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Events Presentations Today - Breaking & Trending Today

Golub Capital BDC, inc (GBDC) Q4 2021 Earnings Call Transcript - Vimarsana News

Golub Capital BDC, inc (GBDC) Q4 2021 Earnings Call Transcript

GBDC earnings call for the period ending September 30, 2021.

Source: fool.com
Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated a-Gal A Enzyme Activity in Patients With Fabry Disease - Vimarsana News

Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated a-Gal A Enzyme Activity in Patients With Fabry Disease

Preliminary data showed that isaralgagene civaparvovec, or ST-920, was generally well tolerated - All four patients in the first two dose cohorts exhibited above normal a-Gal A activity, which was maintained

Wallbox Announces Third Quarter 2021 Revenue 16% Above Budgeted Expectations - Vimarsana News

Wallbox Announces Third Quarter 2021 Revenue 16% Above Budgeted Expectations

The company shared third quarter and year-to-date 2021 results through a Shareholder Letter and Webcast Wallbox N.V. (NYSE: WBX), a leading provider of electric vehicle (EV) charging and energy

TYME Technologies, Inc. to Present at Jefferies London Healthcare Conference - Vimarsana News

TYME Technologies, Inc. to Present at Jefferies London Healthcare Conference

TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), today announced that Richie Cunningham, Chief Executive

ADC Therapeutics SA: ADC Therapeutics to Present at Jefferies Virtual Healthcare Conference - Vimarsana News

ADC Therapeutics SA: ADC Therapeutics to Present at Jefferies Virtual Healthcare Conference

ADC Therapeutics SA: ADC Therapeutics to Present at Jefferies Virtual Healthcare Conference ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company leading the development of novel antibody drug conjugates (ADCs) to treat hematological malignancies and solid tumors, announced today that Chris Martin, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021, at 8:30 a.m. ET. A live webcast of the presentation will be available via the Events Presentations page in the Investors section of ADC Therapeutics' website, ir.adct...